Sai Life Sciences Limited (NSE: SAILIFE)

Market Cap	144.71B
Revenue (ttm)	14.98B
Net Income (ttm)	1.24B
Shares Out	207.99M
EPS (ttm)	6.66
PE Ratio	104.45
Forward PE	81.37
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,115
Average Volume	1,139,964
Open	704.00
Previous Close	691.65
Day's Range	698.20 - 705.60
52-Week Range	650.00 - 808.80
Beta	n/a
RSI	41.38
Earnings Date	n/a

About Sai Life Sciences

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. The company offers medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.

• Industry: Chemicals and Allied Products, not elsewhere classified
• Founded: 1999
• Employees: 2,845
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAILIFE

Financial Performance

In 2023, Sai Life Sciences's revenue was 14.65 billion, an increase of 20.38% compared to the previous year's 12.17 billion. Earnings were 828.09 million, an increase of 729.00%.